Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Disease Cell Type Therapeutic or Technology Institution Stage Project Objectivesort descending Details
Kidney Failure Adult Stem Cell Donor cell therapy Medeor Therapeutics
Clinical Trial, Phase 3
Amyotrophic Lateral Sclerosis Adult Stem Cell Personalized cell therapy BrainStorm
Clinical Trial, Phase 3
Liver Disease iPS Cell Diagnostic Test UCSF
Development Candidate, Proof of Concept
Ovarian Cancer Adult Stem Cell Gene-modified, personalized cell therapy COH
Development Candidate, Proof of Concept
Cartilage defect Adult Stem Cell Biologic The Stone Research Foundation for Sports Medicine and Arthritis
Development Candidate, Proof of Concept
Brain Cancer,
Neurological Disorders
Embryonic Stem Cell Exosomes based therapy UC Irvine
Development Candidate, Proof of Concept
Heart Disease,
Danon Disease
Adult Stem Cell Gene-modified, personalized cell therapy UCSD
Development Candidate, Proof of Concept
Cartilage defect,
Osteoarthritis
Embryonic Stem Cell Therapeutic Approach Scripps Health
Development Candidate, Proof of Concept
COVID-19 Adult Stem Cell Vaccine UCLA
Development Candidate, Proof of Concept
Spinal Cord Injury Embryonic Stem Cell Gene-modified, donor cell therapy UCSD
Development Candidate, Research Insights
Anemia Adult Stem Cell,
iPS Cell
Small molecule therapy Stanford
Development Candidate, Proof of Concept
Dementia iPS Cell Donor cell therapy Gladstone
Development Candidate, Proof of Concept
Type 1 diabetes iPS Cell Biologic UCLA
Development Candidate, Proof of Concept
Heart failure iPS Cell Exosomes based therapy Stanford
Development Candidate, Proof of Concept
Liver Disease iPS Cell Gene-modified, donor cell therapy CHLA
Development Candidate, Proof of Concept
Muscle Injury Adult Stem Cell Personalized cell therapy UCSF
Development Candidate, Proof of Concept
COVID-19,
Respiratory Disorders
iPS Cell Small molecule therapy Sanford-Burnham
Development Candidate, Proof of Concept
Angelman Syndrome,
Autism
iPS Cell Gene Therapy, cell free UC Davis
Development Candidate, Proof of Concept
Skeletal/Smooth Muscle disorders Embryonic Stem Cell,
iPS Cell
Exosomes based therapy Stanford
Development Candidate, Proof of Concept
COVID-19 Adult Stem Cell Gene-modified, donor cell therapy UCLA
Development Candidate, Proof of Concept
Epidermolysis Bullosa iPS Cell Gene-modified, personalized cell therapy Stanford
Development Candidate, Proof of Concept
Sarcoma Adult Stem Cell Gene-modified, personalized cell therapy Stanford
Development Candidate, Proof of Concept
Ovarian Cancer iPS Cell Gene-modified, donor cell therapy UCSD
Development Candidate, Proof of Concept
Type 1 diabetes Embryonic Stem Cell Gene-modified, donor cell therapy Salk
Development Candidate, Proof of Concept
Traumatic Brain Injury Embryonic Stem Cell Exosomes based therapy UC Irvine
Development Candidate, Proof of Concept, Research Insights
Amyotrophic Lateral Sclerosis Adult Stem Cell Donor cell therapy UCSD
Development Candidate, Proof of Concept
Breast Cancer Adult Stem Cell Gene-modified, donor cell therapy Cytonus Therapeutics, Inc.
Development Candidate, Proof of Concept
Heart Disease iPS Cell Model system development Stanford
Development Candidate, Proof of Concept
Heart failure Adult Stem Cell Nucleic acid based therapy Cedars-Sinai
Development Candidate, Proof of Concept
Other Adult Stem Cell Protein/peptide therapy Intact Therapeutics, Inc.
Development Candidate, Proof of Concept
Neurological Disorders iPS Cell Gene Therapy, cell free Navega Therapeutics
Development Candidate, Proof of Concept
Spinal Cord Injury iPS Cell Donor cell therapy Stanford
Development Candidate, Proof of Concept
Multiple Myeloma Somatic Cell Gene-modified, personalized cell therapy UCSF
Development Candidate, Proof of Concept
Blood Disorders Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Development Candidate, Proof of Concept
Multiple Sclerosis Adult Stem Cell Small molecule therapy Scripps
Development Candidate, Proof of Concept
COVID-19,
Respiratory Disorders
iPS Cell Small molecule therapy UCLA
Development Candidate, Proof of Concept
Type 1 diabetes Embryonic Stem Cell Gene-modified, donor cell therapy Lundquist Institute
Development Candidate, Proof of Concept
Kidney Disease Somatic Cell Gene Therapy, cell free UCSF
Development Candidate, Proof of Concept
Inflammatory bowel disease Adult Stem Cell Donor cell therapy Vitabolus, Inc.
Development Candidate, Proof of Concept
Heart Disease iPS Cell Donor cell therapy UC Davis
Development Candidate, Proof of Concept
Neurological Disorders,
Sanfilippo Syndrome/MPS III
iPS Cell Gene-modified, personalized cell therapy UC Irvine
Development Candidate, Proof of Concept
Traumatic Brain Injury iPS Cell Donor cell therapy UC Irvine
Development Candidate, Research Insights
COVID-19 iPS Cell Small molecule therapy UCSD
Development Candidate, Proof of Concept
Pancreatic Cancer Cancer Stem Cell Small molecule therapy UCSD
Development Candidate, Proof of Concept
Brain Cancer Adult Stem Cell Gene-modified, personalized cell therapy UCSF
Development Candidate, Proof of Concept
Huntington's Disease iPS Cell Gene Therapy, cell free UCSD
Development Candidate, Proof of Concept
IPEX Syndrome,
Immune Disease
Vital Research Opportunity Gene Therapy, cell free Stanford
IND
HIV/AIDS Personalized cell therapy COH
IND
Huntington's Disease Embryonic Stem Cell Donor cell therapy UC Irvine
IND
Sickle Cell Disease Adult Stem Cell Gene-modified, personalized cell therapy UCSF
IND

Pages

Icon for csv export